ArticleCureus2025
Fecal Incontinence in Inflammatory Bowel Disease (IBD): Associated Factors and Impact on the Quality of Life of Patients in an IBD Clinic in Switzerland.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevalence of fecal incontinence (FI) among patients with inflammatory bowel disease (IBD) and its associated factors is not well-studied. This research estimated the prevalence of FI in Swiss IBD patients, identified risk factors, and assessed its relationship with well-being, anxiety, and depression.
methodsA cross-sectional study was conducted on adult IBD patients at a Swiss clinic in Bern and Fribourg. The study excluded individuals with a stoma, J-pouch, or unspecified IBD. The survey included 53 questions on demographic and clinical variables. Logistic regression was used to calculate odds ratios (ORs) with 95% confidence intervals (CIs).
resultsAmong 392 respondents, 116 patients (29.5%) reported FI in the previous four weeks. FI was associated with age > 50 years (OR 2.74), vaginal delivery (OR 2.49), disease duration > 15 years (OR 2.04), abdominal pain (OR 2.56), diarrhea (OR 3.70), blood in stool (OR 3.33), >3 bowel movements/day (OR 4.50), nighttime bowel movements (OR 3.98), simple clinical colitis activity index (SCCAI) ≥ 3 (OR 6.06), extraintestinal manifestations (EIMs) (OR 1.64), and a history of anal fistula (OR 2.80). FI was significantly associated with poor well-being (OR 2.64), depression (OR 2.43), and anxiety (OR 1.88).
conclusionFI affects nearly one in three IBD patients and is independently associated with several disease-related factors including a history of anal fistula and the presence of EIM, which is newly described in the literature. FI negatively impacted quality of life, increasing anxiety and depression. These findings emphasize the importance of a comprehensive, patient-centered approach to identify and address risk factors promptly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.